公开(公告)号：US09868743B2

公开(公告)日：2018-01-16

申请号：US14765906

申请日：2014-02-04

Applicant: BRISTOL-MYERS SQUIBB COMPANY

Inventor： Tao Wang ,  Zhongxing Zhang ,  Eric Gillis ,  Paul Michael Scola

IPC: A01N37/18 ,  A61K38/00 ,  A61P1/16 ,  C07D487/08 ,  C07D498/08 ,  A61K31/53

CPC classification number: C07D487/08 ,  A61K31/53 ,  C07D498/08

Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.